Clinical Trial Update: Safety and Immunogenicity of Coadministration of the Candidate Rabies Vaccine ChAdOx2 RabG and Licensed Vaccine [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study to evaluate the safety and immunogenicity of coadministration of the candidate ChAdOx2 RabG rabies vaccine …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• ChAdOx2 RabG
• Licensed rabies vaccine (rabies vaccine)

Snippet

Sponsor: University of Oxford | Conditions: Rabies | Phase 2 | Status: NOT_YET_RECRUITING